Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AMGEN INC.

(AMGN)
  Report
Delayed Nasdaq  -  04:00 2022-09-29 pm EDT
228.41 USD   -1.11%
09/27AstraZeneca Says Bronchial Asthma Treatment Approved in Japan
MT
09/22US Stocks End Lower Thursday Despite Healthcare Gains
MT
09/22US Stocks End Lower Thursday Despite Surge in Healthcare Shares
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about AMGEN INC.
09/27AstraZeneca Says Bronchial Asthma Treatment Approved in Japan
MT
09/22US Stocks End Lower Thursday Despite Healthcare Gains
MT
09/22US Stocks End Lower Thursday Despite Surge in Healthcare Shares
MT
09/21EU approves AstraZeneca-Amgen treatment for severe asthma
RE
09/19Novartis' Biosimilar for Osteoporosis Drug Xgeva Matches Reference Therapy in Safety, E..
MT
09/16Amgen : Is Ready to Meet Growing Demand for Innovative Medicines, Says Bradway in Bloomber..
PU
09/15Consumer group says drugmakers abuse U.S. patent system to keep prices high
RE
09/15Transcript : Amgen Inc. Presents at BofA Securities Global Healthcare Confere..
CI
09/13Asthma Peak Week : What You Need to Know About Indoor Air Pollution
PU
09/13Transcript : Amgen Inc. Presents at Morgan Stanley 20th Annual Global Healthc..
CI
09/12Health Care Up on Cyclical Bias -- Health Care Roundup
DJ
09/12Wall Street posts fourth straight day of gains ahead of CPI report
RE
09/12Amgen announces webcast of 2022 bank of america merrill lynch global healthcare confere..
PR
09/12Wall Street closes higher ahead of CPI report
RE
09/12Wall Street looks to extend its winning streak ahead of CPI report
RE
09/12Bristol-Myers Stock Gains While Amgen Falls on US FDA Approval of Psoriasis Treatment S..
MT
09/12Transcript : Amgen Inc. Presents at European Society for Medical Oncology Ann..
CI
09/12Wall Street hits more than two-week high on energy, tech gains
RE
09/12Wall Street hits more than two-week high on energy, tech gains
RE
09/12Sector Update: Health Care Stocks Climb Premarket Monday
MT
09/12MarketScreener's World Press Review : September 12, ..
MS
09/12Lumakras« (sotorasib) combined with vectibix« (panitumumab) shows confirmed 30% objecti..
PR
09/12Amgen Announces Lumakras Combined with Vectibix (Panitumumab) Shows Confirmed 30% Objec..
CI
09/12Amgen Says Lumakras Has 'Superior' Progression-Free Survival Rate Over Docetaxel in Pat..
MT
09/11Amgen says Lumakras cuts risk of lung cancer progression by 34%
RE
09/11Amgen Announces Detailed Results from the Global Phase 3 CodeBreak 200 Trial
CI
09/09Amgen announces positive new data at eadv 2022 for otezla
AQ
09/08Amgen announces webcast of 2022 morgan stanley global healthcare conference
PR
09/08Transcript : Amgen Inc. Presents at 2022 Wells Fargo Healthcare Conference, S..
CI
09/08Amgen announces positive new data at eadv 2022 for otezla« (apremilast)
PR
09/08Amgen Announces Positive New Data At EADV 2022 for Otezla«
CI
09/07Amgen to webcast investor call at esmo 2022
PR
09/07Transcript : Amgen Inc. Presents at Citi's 17th Annual BioPharma Conference, ..
CI
09/02Amgen announces webcast of 2022 wells fargo healthcare conference
PR
09/02Amgen announces webcast of 2022 citi global healthcare conference
PR
08/31Amgen announces topline data from lumakras phase 3 trial in non-small cell lung cancer
AQ
08/30Amgen Phase 3 Lumakras Study Achieves Progression-Free Survival Primary Endpoint
MT
08/30Amgen Announces Topline Data from LUMAKRAS« Phase 3 Trial in Non-Small Cell Lung Cancer
CI
08/30Amgen to present new, positive clinical and real-world data across inflammation portfol..
PR
08/29Amgen Presents New Compelling Data from the Phase 3 FOURIER Open Label Extension Studie..
CI
08/25Amgen : How Genetic Validation Helped Innovate Medicine for Patients with High Cholesterol
PU
08/23Nasdaq ticks up on hopes of less aggressive rate hikes after weak PMI data
RE
08/23Amgen Reports Positive Results From Phase 3 Study of Soliris Biosimilar Candidate ABP ..
MT
08/23Amgen Reports Top-Line Results From Phase 3 Study of ABP 959, Biosimilar Candidate for ..
MT
08/23Amgen announces positive top-line results from phase 3 study of abp 959, biosimilar can..
PR
08/23Amgen Inc. Announces Positive Top-Line Results from Phase 3 Study of ABP 959, Biosimila..
CI
08/23Amgen Reports Positive Results From Blood-Disease-Treatment Study
DJ
08/22Insider Sell: Amgen
MT
08/22Amgen to present new data at esc congress 2022 highlighting up to 8.5 years of repatha«..
PR
08/17AMGEN INC. : Ex-dividend day for
FA
08/16Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
PU
08/16Amgen Chronicles : Fresh Water and Fresher Ideas About Sustainability in Puerto Rico
PU
08/12Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
PU
08/12Biotech stocks pin bounce back hopes on M&A boost
RE
08/11Senate Finance Committee looks at Amgen taxes, widening drugmaker probe
RE
08/11Senate finance committee chairman wyden sends amgen letter inqui…
RE
08/09Atlantic Equities Adjusts Amgen's Price Target to $182 from $190, Keeps Underweight Rat..
MT
08/08Amgen : Statement on Drug Pricing Provisions Included in “Inflation Reduction Act&rd..
PU
08/08Amgen Presents New Tarlatamab Clinical Data At WCLC 2022
CI
08/08Transcript : Amgen Inc. - Special Call
CI
08/08Transcript : Amgen Inc. Presents at International Association for the Study o..
CI
08/08UBS Adjusts Amgen Price Target to $248 From $242, Maintains Neutral Rating
MT
08/08EFFECTOR Therapeutics Names Douglas Warner Chief Medical Officer
MT
08/07Amgen says Lumakras plus immunotherapy for lung cancer needs further study
RE
08/05Pfizer in advanced talks to buy Global Blood Therapeutics for $5 bln - WSJ
RE
08/05Another case of good news is bad news
MS
08/05Amgen reports second quarter 2022 financial results
AQ
08/05RBC Raises Price Target on Amgen to $236 From $224, Cites 'Another Quarter of Solid Exe..
MT
08/05Morgan Stanley Raises Price Target on Amgen to $257 From $253, Highlights 'Solid Beat' ..
MT
08/05Piper Sandler Adjusts Amgen's Price Target to $265 From $260, Reiterates Overweight Rat..
MT
08/05Amgen Signals Additional $100 Million Hit to Revenue From Foreign Exchange Following Vo..
MT
08/05MarketScreener’s World Press Review : August 5, 2022
MS
08/04Amgen : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS - Form 8-K
PU
08/04Healthcare Shares Slip Amid Deal News -- Healthcare Roundup
DJ
08/04Transcript : Amgen Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on AMGEN INC.